Search
Close this search box.
Logo Asphalion

Important Update for Pharmaceutical Industry Professionals: EMA Submission Changes for Paediatric Procedures via IRIS Portal

May 29, 2024

Asphalion is excited to announce an upcoming transition that will significantly impact the submission process for paediatric procedures within the European Medicines Agency (EMA). Starting from June 4, 2024, the EMA will transition from the current EMA Gateway to the IRIS portal for submissions related to paediatric procedures.

This change will encompass the following submissions:

  • Initial Paediatric Investigation Plan (PIP)
  • Modification of an agreed PIP
  • Product-specific waiver
  • Compliance check
  • Annual report on paediatric deferred measures
  • Confirmation of applicability of a class waiver
  • Discontinuation of Paediatric Development

 

The move to the IRIS portal promises a myriad of benefits, including faster interactions with the EMA, enhanced data quality through integration with other EMA systems, and the ability to monitor the status of applications in real-time from any device. These improvements are designed to increase transparency and efficiency, streamlining the paediatric application process for all stakeholders.

It is relevant to note that in addition to the current template-supported document package provided to EMA, it will be necessary in IRIS to include clinical and quality data associated with the paediatric procedure and formulation development in line with what is already requested by the existing templates.

To facilitate a smooth transition, it is crucial for companies to prepare by ensuring they have an active EMA account. The IRIS platform offers various roles tailored to different functions within the application process, from Industry User Admin to Industry Coordinator, each with specific capabilities to facilitate submission management.

Paediatric procedures that started in advance of the 4th June go-live date will need to be concluded through the IRIS portal.

As a reminder, your company must be registered in SPOR to engage with the IRIS portal.

For any questions or assistance with IRIS or other regulatory processes, please do not hesitate to contact us at: info@asphalion.com

Our team is here to support your company through these changes, ensuring compliance and continued success in the pharmaceutical landscape.

Search News & Events

  • Filter by category

Share

Related news and events

FLYER | Asphalion’s eSubmissions Trainings

The training methodology is mainly online, although it can also be carried out in person as per your request. Training sessions are interactive and can be delivered both in Spanish and English; the number of online attendees is unlimited. Additionally, a training server can be enabled for the attendees to carry out real practical cases.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting